Andreea M. Bujor, MD, PhD
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Rheumatology

MD, Iuliu Hațieganu University of Medicine and Pharmacy
PhD, Iuliu Hațieganu University of Medicine and Pharmacy
MS, Iuliu Hațieganu University of Medicine and Pharmacy



I am an Associate Professor of Medicine in the Section of Rheumatology at Boston University School of Medicine, specializing in scleroderma translational research and in the care of patients with scleroderma.

My research focuses on the interplay between myeloid cells and fibroblasts in scleroderma-associated cardiac fibrosis. Our project investigating the role of the transcription factor Fli1 in myeloid cells has received funding from the NIH, American Heart Association, and Rheumatology Research Foundation. Additionally, we are exploring a method called spatial frequency domain imaging as a non-invasive tool for assessing skin fibrosis in scleroderma patients, a project supported by the Scleroderma Clinical Trials Consortium and National Scleroderma Foundation.

Beyond research, I am deeply committed to mentoring and education. As the Associate Program Director for the Rheumatology Fellowship, I have mentored trainees at all levels, and received an Outstanding Mentor Award from UROP. I regularly lecture on scleroderma and rheumatology and lead board review sessions for fellows. In recognition of my contributions to clinical care and research, I was honored as one of Boston’s Top Doctors in 2024 and 2025.

Diversity, Equity, Inclusion and Accessibility

2020-2021 Clinical preceptor for two Rheumatology fellows from underrepresented minorities
2022- Research mentor for a Rheumatology fellows from underrepresented minorities
2021- Faculty mentor for our monthly JEDI “Justice, equity, diversity and inclusion” sessions, Division of Rheumatology, BUMC, Boston, MA

Associate Program Director
Boston University
Arthritis & Autoimmune Diseases Research Center
Rheumatology Fellowship Program

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research




Collaborative, National Quality and Efficacy Registry for Tracking Disease Progression in Systemic Sclerosis (Scleroderma)
08/13/2024 - 02/28/2029 (PI)
Scleroderma Foundation


The role of FLI1 in myeloid cells and its contribution to cardiac fibrosis
09/15/2021 - 06/30/2026 (PI)
NIH/National Heart, Lung, and Blood Institute
5R01HL155955-04

Spatial frequency domain imaging as a new method to quantify skin changes in scleroderma
04/01/2023 - 03/31/2025 (PI)
Scleroderma Foundation


Spacial frequency domain imaging as a new method to quantify skin changes in Scleroderma
07/01/2022 - 06/30/2023 (PI)
Scleroderma Clinical Trials Consortium


The role of myeloid Fli1 in organ fibrosis in systemic sclerosis
07/01/2020 - 12/31/2021 (PI)
Rheumatology Research Foundation




Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Darbousset R, Senkpeil L, Kuehn J, Balu S, Miglani D, Dillon E, Fromson C, Elahee M, Jarrot PA, Montesi SB, Rao DA, Ware J, Wagner DD, Bujor AM, Gutierrez-Arcelus M, Nigrovic PA. A GPVI-platelet-neutrophil-NET axis drives systemic sclerosis. bioRxiv. 2025 Jan 24. PMID: 39896646; PMCID: PMC11785050; DOI: 10.1101/2025.01.21.634123;
     
  2. Lui JK, Cozzolino M, Winburn M, Trojanowski MA, Soylemez Wiener R, LaValley MP, Bujor AM, Gopal DM, Klings ES. Clustering regional patterns of left ventricular longitudinal strain in systemic sclerosis-related pulmonary hypertension. Int J Cardiol. 2025 Feb 15; 421:132891.View Related Profiles. PMID: 39662748; PMCID: PMC11747944; DOI: 10.1016/j.ijcard.2024.132891;
     
  3. Yamashita T, Kaplan U, Chakraborty A, Marden G, Gritli S, Roh D, Bujor A, Trojanowski M, Ligresti G, Browning JL, Trojanowska M. ERG Regulates Lymphatic Vessel Specification Genes and Its Deficiency Impairs Wound Healing-Associated Lymphangiogenesis. Arthritis Rheumatol. 2024 Nov; 76(11):1645-1657.View Related Profiles. PMID: 38965683; PMCID: PMC11521767; DOI: 10.1002/art.42944;
     
  4. Raslan AA, Pham TX, Lee J, Kontodimas K, Tilston-Lunel A, Schmottlach J, Hong J, Dinc T, Bujor AM, Caporarello N, Thiriot A, von Andrian UH, Huang SK, Nicosia RF, Trojanowska M, Varelas X, Ligresti G. Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis. Nat Commun. 2024 Jun 27; 15(1):5449.View Related Profiles. PMID: 38937456; PMCID: PMC11211333; DOI: 10.1038/s41467-024-49545-x;
     
  5. Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2024 Jun; 38(3):657.View Related Profiles. PMID: 36662449; PMCID: PMC11528702; DOI: 10.1007/s10557-023-07431-6;
     
  6. Lui JK, Cozzolino M, Winburn M, Trojanowski MA, Wiener RS, LaValley MP, Bujor AM, Gopal DM, Klings ES. Role of Left Ventricular Dysfunction in Systemic Sclerosis-Related Pulmonary Hypertension. Chest. 2024 Jun; 165(6):1505-1517.View Related Profiles. PMID: 38128607; PMCID: PMC11177103; DOI: 10.1016/j.chest.2023.12.018;
     
  7. Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension. Lung. 2023 Dec; 201(6):565-569.View Related Profiles. PMID: 37957388; PMCID: PMC11037922; DOI: 10.1007/s00408-023-00646-2;
     
  8. Vakhshoorzadeh J, Lui JK, Sangani RA, Trojanowski MA, Bujor AM, LaValley MP, Klings ES. Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension. Respir Med. 2023 Sep; 216:107333.View Related Profiles. PMID: 37336329; PMCID: PMC10666733; DOI: 10.1016/j.rmed.2023.107333;
     
  9. Pilvar A, Mehendale AM, Karrobi K, El-Adili F, Bujor A, Roblyer D. Spatial frequency domain imaging for the assessment of scleroderma skin involvement. Biomed Opt Express. 2023 Jun 01; 14(6):2955-2968.View Related Profiles. PMID: 37342706; PMCID: PMC10278615; DOI: 10.1364/BOE.489609;
     
  10. El-Adili F, Lui JK, Najem M, Farina G, Trojanowska M, Sam F, Bujor AM. Correction: Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications. Arthritis Res Ther. 2023 Jan 23; 25(1):11.View Related Profiles. PMID: 36691037; PMCID: PMC9869504; DOI: 10.1186/s13075-023-02993-0;
     
Showing 10 of 43 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 43 publications over 12 distinct years, with a maximum of 9 publications in 2023

YearPublications
20081
20106
20114
20125
20132
20192
20203
20211
20225
20239
20244
20251


2021 Boston University: Outstanding Mentor Award, UROP
2020 Rheumatology Research Foundation: Tobé and Stephen E. Malawista, MD, Endowment in Academic Rheumatology
2020 American Heart Association: Career Development Award
2019 16th International Workshop on Scleroderma Research: SCTC Travel Award
2010 Scleroderma Foundation: Walter A. Coyle Memorial Research Grant Award
2006 9th International Workshop in SSc, Boston, MA: Young Investigator Travel Award
2006 Arthritis Foundation: Postdoctoral Fellowship Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

scleroderma
Fibrosis
Fibroblasts
Gout
Immunity
Systemic Sclerosis

As an Associate Professor of Rheumatology and Associate Program Director for the Rheumatology Fellowship, I have a deep commitment to mentoring and developing the next generation of physician-scientists in rheumatology, with a particular focus on scleroderma research. My expertise lies in the molecular mechanisms of fibrosis, particularly in scleroderma and cardiac fibrosis, and I bring this knowledge to bear in my mentoring relationships.
I have successfully mentored numerous trainees, including undergraduate and medical students, residents, rheumatology fellows, and postdoctoral research fellows, guiding them through research projects and supporting their career development. My mentoring philosophy centers on nurturing each individual's unique strengths and interests, helping them to align their research and clinical pursuits with their personal goals and values.
Ultimately, my goal as a mentor is to foster independence, critical thinking, and scientific curiosity in my mentees. I aim to help them develop the skills and confidence necessary to become successful physician and/or scientists, capable of making significant contributions to the field of rheumatology and, more broadly, to improving patient care through innovative research.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Education Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

75 E. Newton St Evans Building
Boston MA 02118
Google Map


Bujor's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department